FDA authorizes new rapid COVID-19 test, says capacity will double

2021-10-05 | , The Hill

October 4, 2021 - The Food and Drug Administration (FDA) on Monday authorized a new rapid, at-home COVID-19 test, in a move it said is expected to double the availability of such tests in the coming weeks. The FDA said it has authorized a coronavirus test from the company ACON Laboratories. It is not the first authorization of such a test, which can deliver results in as little as 15 minutes, but, amid supply shortages, the move could be key in boosting their availability. Jeff Shuren, a top FDA official, said the move "is expected to double rapid at-home testing capacity in the U.S. over the next several weeks. Read the full article here.

 

https://cqrcengage.com/adea/home?2&utm_source=mgi&utm_medium=facebook&utm_campaign=engagement_member

2016 American Dental Education Association (ADEA), 655 K Street, NW, Suite 800, Washington, DC 20001 (202) 289-7201